Learning impairments induced by glutamate blockade using dizocilpine (MK-801) in monkeys

British Journal of Pharmacology

Volumn 125, Issue 5, 1998, Pages 1013-1018

  Harder, J A ^a,b   Aboobaker, A A ^a   Hodgetts, T C ^a   Ridley, R M ^a  

^a Department Experimental Psychology   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Alzheimer's disease; Cognition; Dizocilpine; Glutamate; Hippocampus; Learning; Neocortex; NMDA antagonist; Primate; Pyramidal cells

Indexed keywords

DIZOCILPINE; GLUTAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOMATION; COGNITION; CONTROLLED STUDY; DEPTH PERCEPTION; DOSE RESPONSE; LEARNING DISORDER; LOCOMOTION; MARMOSET; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; VISUAL DISCRIMINATION;

ANIMALS; CALLITHRIX; DISCRIMINATION (PSYCHOLOGY); DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMATES; HUMANS; LEARNING; LEARNING DISORDERS; MALE; MOTOR ACTIVITY; VISUAL PERCEPTION;

EID: 0031730076     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702178     Document Type: Article

References (26)

1. BOWEN, D.M., FRANCIS, P.T., CHESSELL, I.P. & WEBSTER, M.T. (1994). Neurotransmission - the link integrating Alzheimer research? Trends Neurosci., 17, 149.
2. BOWEN, D.M., FRANCIS, P.T., PANGALOS, M.N., STEPHENS, P.H., PROCTOR, A.W. & CHESSELL, I.P. (1992). "Traditional" pharmacotherapy may succeed in Alzheimer's disease. Trends Neurosci., 15, 85.
3. BOYCE, S., RUPNIAK, N.M.J., STEVENTON, M.J., COOK, G. & IVERSEN, S.D. (1991). Psychomotor activity and cognitive disruption attributable to NMDA, but not sigma, interactions in primates. Behav. Brain. Res., 42, 115-121.
4. BRAAK, H. & BRAAK, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta. Neuropathol., 82, 239-259.
5. BUFFALO, E.A., GILLAM, M.P., ALLEN, R.R. & PAULE, M.G. (1994). Acute behavioural effects of MK-801 in rhesus monkeys: assessment using an operant test battery. Pharmacol. Biochem. Behav., 48, 935-940.
6. DEKOSKY, S.T. & SCHEFF, S.W. (1990). Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol., 27, 457-464.
7. FINE, A., HOYLE, C., MACLEAN, C.J., LEVATTE, T.L., BAKER, H.F. & RIDLEY, R.M. (1997). Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys. Neurosci., 81, 331-343.
8. FRANCIS, P.T., CROSS, A.J. & BOWEN, D.M. (1994). Neurotransmitters and neuropeptides. In Alzheimer Disease. ed. Terry, R.D., Katzman, R. & Bick, K.L. pp. 247-261. New York: Raven Press Ltd.
9. FRANCIS, P.T., PANGALOS, M.N. & BOWEN, D.M. (1992). Animal and drug modelling for Alzheimer synaptic pathology. Prog. Neurobiol., 39, 517-545.
10. HARDER, J.A., BAKER, H.F. & RIDLEY, R.M. (1998). The role of the central cholinergic projections in cognition: Implications of the effects of scopolamine on discrimination learning in monkeys. Brain. Res. Bull., 45, 319-326.
11. 1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset. Psychopharmacol., 127, 245-254.
12. IVERSEN, L.L. & KEMP, J.A. (1996). Non-competitive NMDA antagonists as drugs. In The NMDA receptor. ed: Collingridge, G.L. pp. 469-486.
13. 3H]glutamate-binding sites in rat brain. J. Neurosci., 5, 2909-2919.
14. MORRIS, R.G.M., ANDERSON, E., LYNCH, G.S. & BAUDRY, M. (1986). Selective impairment of spatial learning and blockade of long-term potentiation by N-methyl-D-aspartate receptor antagonist AP5. Nature, 319, 774-776.
15. MURRAY, T.K., RIDLEY, R.M., SNAPE, M.F. & CROSS, A.J. (1995). The effect of dizocilpine (MK-801) on spatial and visual discrimination tasks in the rat. Behav. Pharmacol., 6, 540-549.
16. MURRAY, T.K. & RIDLEY, R.M. (1997). the effect of dizocilpine (MK-801) on conditional discrimination learning in the rat. Behav. Pharmacol., 8, 383-388.
17. OTTERSEN, O.P. (1991). Excitatory amino acid neurotransmitters: anatomical systems. In Excitatory amino acid antagonists. ed: Meldrum, B.S. pp. 14-38. Oxford: Blackwell Scientific.
18. RIDLEY, R.M., AITKEN, D.M. & BAKER, H.F. (1989). Learning about rules but not about reward is impaired following lesions of the cholinergic projection to the hippocampus. Brain Res., 502, 306-318.
19. RIDLEY, R.M. & BAKER, H.F. (1991). A critical evaluation of monkey models of amnesia and dementia. Brain Res. Rev., 16, 15-37.
20. RIDLEY, R.M., SAMSON, N.A., BAKER, H.F. & JOHNSON, J.A. (1988). Visuospatial learning impairment following lesion of the cholinergic projection to the hippocampus. Brain Res., 456, 71-87.
21. RIDLEY, R.M., TIMOTHY, C.J., MACLEAN, C.J. & BAKER, H.F. (1995). Conditional learning and memory impairments following neurotoxic lesion of the CA1 field of the hippocampus. Neurosci., 67, 263-275.
22. ROBINSON, G.S., CROOKS, G.B., SHINKMAN, P.G. & GALLAGHER, M. (1989). Behavioural effects of MK-801 mimic deficits associated with hippocampal damage. Psychobiol., 17, 156-164.
23. SHAPIRO, M.L. & CARAMANOS, Z. (1990). NMDA antagonist MK-801 impairs acquisition but not performance of spatial working and reference memory. Psychobiol., 18, 231-243.
24. TERRY, R.D., MASLIAH, E. & SALMON, D.P. (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol., 30, 572-580.
25. VAN HOESEN, G.W. (1982). The primate parahippocampal gyrus: new insights regarding its cortical connections. Trends Neurosci., 5, 345-350.
26. WONG, E.H.F., KEMP, J.A., PRIESTLY, T., KNIGHT, A.R., WOODRUFF, G.N. & IVERSEN, L.L. (1986). The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. U.S.A., 83, 7104-7108.